EU AI Act dates for medical device AI after the Omnibus

The Digital Omnibus on AI, in force 27 July 2026, moves standalone high-risk AI to 2 December 2027 and AI in regulated products such as devices to 2 August 2028.

  • EU

1The Omnibus was published on 24 July 2026 and has been in force since 27 July 2026; Parliament endorsed it on 16 June and the Council approved it on 29 June.

2Annex III high-risk obligations move to 2 December 2027.

3Annex I product-embedded obligations, including MDR medical devices, move to 2 August 2028.

4Medical devices did not get a full carve-out, so dual AI Act and MDR exposure remains, with a limited overlap mechanism.

Limits of this page. We read law-firm summaries of the Omnibus, not EUR-Lex, which returned no content when we tried. The regulation number (EU) 2026/1744 is consistent with the Official Journal reference but we could not confirm it on EUR-Lex. One outlying source gives 2 December 2026 for product-embedded systems; the other sources disagree with it.

What is the Digital Omnibus on AI?

It is an EU amendment that postpones when the AI Act’s high-risk obligations apply. After a provisional political deal on 7 May 2026, Parliament endorsed it on 16 June 2026 and the Council approved it on 29 June 2026. It was published in the Official Journal on 24 July 2026 and entered into force on 27 July 2026.

What are the new dates?

Category New date Medical-device relevance
Annex III standalone high-risk AI 2 December 2027 Applies to AI in listed use cases, not to devices as such
Annex I product-embedded AI 2 August 2028 Includes AI in devices regulated under the MDR
Marking duties for earlier systems (Article 50) 2 December 2026 Transparency of AI-generated content
AI regulatory sandboxes 2 August 2027 Member-state sandboxes

Why did medical devices not get a carve-out?

Machinery received a full carve-out. Medical devices did not, so a device with AI can face both the AI Act and the MDR, with a limited mechanism to reduce overlap through implementing acts.

What does this mean for evidence?

The delay gives device manufacturers about another two years, but the MDR already requires clinical evaluation and post-market surveillance. A manufacturer that builds a measurement record now can reuse it later. See the FDA’s PCCP guidance for the US equivalent on model updates.

What did we not verify?

EUR-Lex text and the regulation number. One outlier source gives 2 December 2026 for product-embedded systems, which contradicts the rest.

Frequently asked questions

When do high-risk AI rules apply to medical devices in the EU?

For AI embedded in regulated products, which includes medical devices under the MDR, the Digital Omnibus moves the high-risk obligations to 2 August 2028. Standalone high-risk AI listed in Annex III moves to 2 December 2027.

Is the Digital Omnibus on AI final?

Yes, according to law-firm reporting: it was published in the Official Journal on 24 July 2026 and entered into force on 27 July 2026. We could not read EUR-Lex to confirm the regulation number.

Does the delay change MDR obligations?

No. The delay concerns AI Act obligations. Medical devices remain subject to the MDR, and the Omnibus did not give medical devices the full carve-out that machinery received.

Sources

  1. The Digital Omnibus on AI enters into force todayLewis Silkin · 2026-07-27
  2. EU AI Act omnibus agreement: postponed high-risk deadlinesGibson Dunn · 2026-05
  3. The EU Digital Omnibus on AI: what the political deal meansTaylor Wessing · 2026-05

Found something out of date? Write to hello@precision.example and we will fix it.

Written and reviewed byPrecision research teamHealthcare AI evaluation research